Target intelligence / Profile preview

Alpha-mannosidase (Jack bean) (JBM)

Target
JBM
Molecular classification
Enzyme, Glycosyl hydrolase, Glycosyl hydrolase family 38
01

Overview

Jack bean alpha-mannosidase is a zinc-dependent glycosyl hydrolase (EC 3.2.1.24) purified from the seeds of the Jack bean plant, Canavalia ensiformis (UniProt: P80033). It belongs to the Glycosyl Hydrolase Family 38 (GH38) and is characterized by its ability to hydrolyze terminal, non-reducing alpha-D-mannose residues from various glycoconjugates (CAZy Database). In the field of glycobiology, this enzyme is a standard tool for the structural analysis and sequencing of N-linked oligosaccharides due to its broad substrate specificity. Although it is a plant-derived enzyme, it serves as a primary biochemical model for human alpha-mannosidases, which are involved in glycoprotein maturation and lysosomal degradation. It is frequently used in drug discovery as a surrogate target to screen for inhibitors like swainsonine, which are investigated for their anti-tumor and immunomodulatory properties (PMID: 1566718). These inhibitors typically act by mimicking the transition state of the mannosyl residue, thereby competitively blocking the enzyme's active site (PMID: 8413645). Consequently, Jack bean alpha-mannosidase plays a vital role in understanding the pharmacology of glycomimetics intended for treating cancer, viral infections, and metabolic disorders.

Other names
Alpha-D-mannoside mannohydrolaseJack bean alpha-mannosidaseCanavalia ensiformis alpha-mannosidaseAlpha-mannosidase 1
02

Mechanism of action

Competitive inhibition of the catalytic site by transition-state analogs, preventing the cleavage of terminal alpha-mannosyl residues from glycoproteins (PMID: 8413645).

03

Biological functions

Carbohydrate metabolismGlycan processingHydrolysis of alpha-D-mannose residues
04

Disease associations

CancerViral infectionLysosomal storage disorder
05

Safety considerations

Off-target inhibition of human lysosomal alpha-mannosidaseInduction of mannosidosis-like symptomsPotential neurotoxicity
06

Interacting drugs

Swainsonine

4 more in the full profile.

Beyond the preview

Go deeper on Alpha-mannosidase (Jack bean) (JBM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-mannosidase (Jack bean) (JBM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call